病毒灵
病毒灵的相关文献在1990年到2022年内共计137篇,主要集中在畜牧、动物医学、狩猎、蚕、蜂、皮肤病学与性病学、中国医学
等领域,其中期刊论文134篇、专利文献58380篇;相关期刊108种,包括大众健康、健康必读(上旬刊)、中国社区医师等;
病毒灵的相关文献由210位作者贡献,包括刘万珍、刘丽强、匡华等。
病毒灵—发文量
专利文献>
论文:58380篇
占比:99.77%
总计:58514篇
病毒灵
-研究学者
- 刘万珍
- 刘丽强
- 匡华
- 宋珊珊
- 容建清
- 张秉乾
- 徐丽广
- 杨卫东
- 王晓阳
- 等
- 胡拥明
- 胥传来
- 袁正宇
- 许晓昕
- 马伟
- 丁义全
- 丁永富
- 于连智
- 付阳
- 任红燕
- 余国俊
- 冀连梅
- 刘丰
- 刘思当
- 刘成生
- 刘春刚
- 刘泉洪
- 刘玉峰
- 刘玉芬
- 刘郁芬
- 刘霞
- 北方
- 华旦
- 单忠义
- 卢小春
- 古耘
- 叶养玉
- 吕传卫
- 吴叶青
- 吴志(整理)
- 吴晓玲
- 周汝宜
- 周红
- 唐义
- 夏海涛
- 姜静璐
- 孙大明
- 孙庆云
- 孙振辉
- 孙桂芳
-
-
-
刘泉洪
-
-
摘要:
目的:流感是临床常见病,好发于冬春之交及夏秋之交季节,传染性强,对民众的健康危害大,西药治疗效果欠佳,笔者运用雷氏宣透膜原法进行治疗,效果显著,疗程短,无副作用.与西药病毒灵对照,有显著性优势.
-
-
蔡光辉;
朱中梁
-
-
摘要:
Objectives:To observe the clinical effect of CO2 laser combined virustat in the treatment of ure-thral condyloma acuminatum.Methods:1 26 patients with urethral condyloma acuminatum in our hospital between April 201 2 and February 201 4 were selected as the research object,and randomly divided into laser group of 54 ca-ses and joint group of 72 cases.Laser group were treated by carbon dioxide laser therapy;joint group were treated by carbon dioxide laser combination virustat.The cure rate and recurrence rate of patients in the two groups were compared and analyzed.Results:All the 1 26 patients in the study showed a higher cure rate,laser group of 96. 30% (52 cases),joint group of 95. 83%(69 cases),with no statistically significant difference,P<0. 05;Af-ter treatment,20 cases in the laser group relapsed,a recurrence rate of 37. 04%,significantly higher than the 8. 33% of the joint group,with statistically significant difference between groups,P<0. 05 .Conclusion:For pa-tients with urethral condyloma acuminatum,carbon dioxide laser combined virustat shows significant treatment effect,which not only ensure the cure rate,but also can effectively reduce the recurrence rate.Being safe and relia-ble,it is worthy of clinical promotion.%目的:观察CO2激光联合病毒灵治疗尿道尖锐湿疣的临床治疗效果。方法:以2012年4月-2014年2月间我院收治的126例尿道尖锐湿疣患者为研究对象,按抛硬币法将其随机分为激光组54例与联合组72例。激光组患者采用CO2激光疗法;联合组患者采用CO2激光联合病毒灵疗法,对比两组患者治愈率与复发率,分析临床治疗效果。结果:参与本次研究的126例患者均获得较高的治愈率,激光组为96.30%(52例),联合组为95.83%(69例),组间对比不明显,不具备统计学意义,P<0.05;接受治疗后,激光组复发20例,复发率为37.04%,明显高于联合组的8.33%,组间对比具有统计学意义,P<0.05。结论:对尿道尖锐湿疣患者采用CO2激光联合病毒灵方案,治疗效果显著,不仅能保证治愈率、还能有效降低复发率,安全可靠,值得临床推广。
-
-
王广文;
牛玉娟;
胡东方;
王彤彤;
张振东;
吕传卫;
屈亚锦;
李宁;
刘思当
-
-
摘要:
为寻求抗ALV-J感染雏鸡用药物,通过CCK-8试剂盒检测细胞活力以确定利巴韦林、病毒灵和黄芪多糖对DF1细胞的最大安全浓度,用ELISA试剂盒检测ALV-J P27抗原表达量,以确定上述抗病毒药物体外抗ALV-J活性。结果显示,利巴韦林、病毒灵和黄芪多糖对DF1细胞的最大安全浓度分别为0.0391、0.0625和0.0625 mg/mL。在安全范围内,利巴韦林对P27的表达量具有明显的抑制作用,黄芪多糖在0.0039~0.0625 mg/mL安全浓度范围内明显抑制P27的表达,病毒灵在安全范围内对P 27的表达基本上没有抑制作用。试验表明,利巴韦林和黄芪多糖对ALV-J的增殖有明显的抑制作用,有望作为该病净化的辅助性防制药物。%To acquire the anti-ALV-J drug, P27 expression quantity influence of Ribavirin, moroxydine and astragalan on ALV-J ( NX0101 ) are researched by the CCK 8 kits cell detected for the maximum safe concentrations of the three antiviral drugs on DF1 cell and ALV-J P27 antigen ELISA test kit for P27 expression quantity.The results show that the maximum safe concentrations of Ribavirin, moroxydine and astragalan on DF1 cell are 0. 039, 0. 0625 and 0. 0625 mg/mL. The obvious inhibitory concentration of Ribavirin for the P27 expression quantity in the the scale of safe concentrations is 0.0391 mg/mL. The concentration range of astragalan inhibiting the expression of ALV-J P27 are 0.0039~0.0625 mg/mL. However, varied concentration of moroxydine in the research has no inhabitory effect on P27 expression quantity. The aforementioned results show that ribavirin and astragalan can inhabit the propogation of ALV-J, providing a perfect prospect for the ALV-J eradication in chinken in the future.
-
-
-
-
-
-